NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Ocean Biomedical Inc. shares have tumbled to a 52-week low, reaching a price level of just $0.28. With a market ...

Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, ...

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products ...

Insiders were net buyers of Lifecore Biomedical, Inc.'s (NASDAQ:LFCR ) stock during the past year. That is, insiders bought more stock than they sold. While insider transactions are not the most ...

Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty ...

Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer healthcare and ...

Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional ...

Ondine Biomedical announced a $4m equity investment from hInsight-NX, a subsidiary of US medical facilities giant HCA ...

The firm said New Jersey-based hInsight-NX LLC, a subsidiary of Tennessee-based HCA Healthcare Inc, has agreed to invest USD4 million in Ondine to support the company's strategic objectives, which ...